Supplementary Table 3 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

Supplementary Table 3 from Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

<p>Supplementary Table 3. Overview of included patients and genetic findings.HGVS=Human Genome Variation Society.</p>

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Bianca Tesi (17141978) (author)
Další autoři:	Anna Robelius (21718417) (author), Berivan Baskin (21718420) (author), Vladimir Lazarevic (21718423) (author), Stefan Deneberg (21718426) (author), Martin Höglund (21718429) (author), Linda Fogelstrand (21718432) (author), Johanna Ungerstedt (21718435) (author), Tatjana Pandzic (21718438) (author), Magnus Tobiasson (17142020) (author), Hege Gravdahl Garelius (21718441) (author), Ekaterina Kuchinskaya (21718444) (author), Fredrik Persson (21718447) (author), Helena Ågerstam (21718450) (author), Helene Hallböök (21718453) (author), Thoas Fioretos (8653719) (author), Jessika Nordin (8653686) (author), Anna Norberg (21718456) (author), Ann-Charlotte Thuresson (21718459) (author), Sören Lehmann (21718462) (author), Claes Ladenvall (15352476) (author), Gisela Barbany (21718465) (author), Lovisa Vennström (21718468) (author), Elisabeth Ejerblad (21718471) (author), Lucia Cavelier (15352473) (author), Jörg Cammenga (21718474) (author), Martin Jädersten (21718477) (author), Eva Hellström-Lindberg (17142032) (author), Panagiotis Baliakas (15352479) (author)
Vydáno:	2025
Témata:	Cancer Cancer Risk Factors Cancer Biology Therapeutic Research and Development Clinical Research and Trials Carcinogenesis Tumor initiation and promotion Endogenous Risk Factors Hematological Cancers Leukemias Precision Medicine Translational Research
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!